Pneumonia based on Schwartz

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have all the key content from Schwartz's on pneumonia. Let me compile the comprehensive answer.

Pneumonia - Schwartz's Principles of Surgery (11th Ed.)

Schwartz's covers pneumonia primarily from a surgical perspective, addressing it in the contexts of postoperative complications, ventilator-associated infection, lung abscess, aspiration, and bronchiectasis.

1. Postoperative Pneumonia & Predisposing Factors

Pulmonary atelectasis is a key precursor - it reduces functional residual capacity (FRC) and predisposes to pneumonia. Contributing factors include:
  • Poor pain control → inadequate inspiratory effort → lower lobe collapse
  • Inadequate pulmonary toilet → bronchial plugging, lobar collapse
  • Aspiration (from anesthesia, stroke, drugs/alcohol, esophageal disease)
Prevention of atelectasis/pneumonia:
  • Sit patient >45° (increases FRC by ≥700 mL)
  • Early ambulation
  • Adequate pain control - epidural analgesia significantly lowers pneumonia risk vs. patient-controlled analgesia
  • Head of bed at 30-45° for ventilated patients
  • Adequate tidal volumes (8-10 mL/kg) in ventilated patients

2. Ventilator-Associated Pneumonia (VAP)

Pneumonia is the second most common nosocomial infection overall and the most common infection in ventilated patients.
  • VAP occurs in 15% to 40% of ventilated ICU patients
  • Probability rate: 5% per day, up to 70% at 30 days
  • 30-day mortality of nosocomial pneumonia: up to 40% (depends on organism and timeliness of antibiotics)
Diagnosis requires:
  • Abnormal chest X-ray
  • Fever
  • Productive cough with purulent sputum
  • No other obvious fever source
The presence of two clinical findings + CXR changes significantly increases diagnostic likelihood. Bronchoalveolar lavage (BAL) for Gram stain and culture is recommended; quantitative cultures (threshold: ≥100,000 CFU) help confirm diagnosis.
Organisms:
  • Nosocomial pneumonia: 60-70% gram-negative bacteria
  • Pseudomonas and Acinetobacter spp. are particularly virulent - double antibiotic coverage may be appropriate if local prevalence is high
  • Immunosuppressed patients: also susceptible to Salmonella, Legionella, Pneumocystis carinii (jirovecii), atypical mycobacteria, fungi
Treatment:
  • Begin broad-spectrum antibiotics immediately once pneumonia suspected
  • Narrow spectrum once culture sensitivities are known
  • Track the institution's antibiogram every 6-12 months - one of the most helpful tools in managing pneumonia
Prevention of VAP: Wean from mechanical ventilation as soon as oxygenation and inspiratory effort allow. Protocol-driven approaches are recognized as beneficial.

3. Aspiration Pneumonitis vs. Aspiration Pneumonia

FeaturePneumonitisPneumonia
CauseChemical injury from aspirated gastric acidBacterial infection from aspirated material
AntibioticsNot indicatedRequired (broad-spectrum initially)
TreatmentSupportive care, oxygenation (similar to ARDS management); early aggressive bronchoscopy for suctioningAntibiotics guided by culture
MortalityUp to 70-80% in hospitalized patientsDepends on organism and timeliness
Forced diuresis for anasarca/over-resuscitation remains controversial - complications include electrolyte disturbances, metabolic alkalosis, hypotension, and acute kidney injury.

4. Lung Abscess (Necrotizing Pneumonia)

Etiology Classification

Primary (lung as source):
  • Necrotizing pneumonia - caused by S. aureus, Klebsiella, Pseudomonas, Mycobacterium, Bacteroides, Fusobacterium, Actinomyces, Entamoeba, Echinococcus
  • Aspiration pneumonia - anesthesia, stroke, drugs/alcohol
  • Esophageal disease - achalasia, Zenker's diverticulum, GERD
  • Immunodeficiency - cancer, chemotherapy, diabetes, organ transplantation, steroid therapy, malnutrition
Secondary (lung involved from elsewhere):
  • Bronchial obstruction (neoplasm, foreign body)
  • Systemic sepsis (septic pulmonary emboli, seeding of pulmonary infarct)
  • Pulmonary trauma (infected hematoma/contusion, contaminated foreign body)
  • Direct extension from extraparenchymal infection (pleural empyema, mediastinal/hepatic/subphrenic abscess)

Microbiology

Post-aspiration lung abscesses are typically polymicrobial (average 2-4 isolates):
  • ≥50% purely anaerobic bacteria
  • 25% mixed aerobes + anaerobes
  • ≤25% aerobes only

Clinical Features

  • Productive cough, fever (>38.9°C), chills, leukocytosis (>15,000 cells/mm³)
  • Weight loss, fatigue, malaise, pleuritic chest pain, dyspnea
  • More indolent course possible: weeks-months of low-grade fever, night sweats, anemia
  • After aspiration: cavitation in 1-2 weeks; 40-75% produce putrid/foul-smelling sputum
  • Severe complications (massive hemoptysis, pyopneumothorax, septic shock) are rare in the antibiotic era
  • Mortality: 5-10% overall; 9-28% in immunosuppressed patients

Diagnosis

  • CXR is primary tool - shows density/mass with thin-walled cavity; air-fluid level indicates communication with tracheobronchial tree
  • CT chest when CXR is equivocal - clarifies diagnosis, identifies endobronchial obstruction
  • Differential: cavitating lung carcinoma, loculated empyema, infected lung cysts/bullae, TB, bronchiectasis, fungal infections, Wegener's granulomatosis
  • Bronchoscopy for culture (ideally before antibiotics)

Treatment

Medical treatment is primary - spontaneous drainage via the tracheobronchial tree is usual.
Surgical indications (Table 19-18):
  1. Failure of medical therapy
  2. Abscess under tension
  3. Abscess increasing in size during appropriate treatment
  4. Contralateral lung contamination
  5. Abscess >4-6 cm in diameter
  6. Necrotizing infection with multiple abscesses, hemoptysis, abscess rupture, or pyopneumothorax
  7. Inability to exclude cavitating carcinoma
Drainage options:
  • Tube thoracostomy
  • Percutaneous (radiographically guided) drainage
  • Surgical cavernostomy
  • Surgical resection required in <10% of patients
  • Lobectomy is preferred for bleeding or pyopneumothorax
  • Intraoperative: protect contralateral lung with double-lumen tube, bronchial blocker, or contralateral mainstem intubation
  • Surgical treatment: 90% success rate, mortality 1-13%

5. Pneumonia as a Cause of Bronchiectasis

Diffuse pneumonic processes - including necrotizing bacterial pneumonia, pertussis/measles pneumonia, severe influenza, and varicella pneumonia - can lead to widespread bronchiectasis (permanent dilation of bronchi with wall thickening). This is a key acquired cause of bronchiectasis, particularly in post-infectious settings.

6. Inhalation Injury & Pneumonia (Burn Patients)

  • Ventilator-associated pneumonia is especially common in patients with inhalation injury
  • BAL within 24 hours of inhalation injury has a high rate of positive cultures, helping isolate organisms early
  • "Pneumonia" nomenclature is complicated in this population by the background of inhalation injury

Sources: SCHWARTZ'S PRINCIPLES OF SURGERY, 11th Edition - Chapters on Surgical Complications (Ch. 12), Critical Care (Ch. 13), Chest Wall, Lung, Mediastinum & Pleura (Ch. 19), and Burns (Ch. 8)
This is a shared conversation. Sign in to Orris to start your own chat.